Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2026 | Low-dose tamoxifen could prevent breast cancer in at-risk young premenopausal women

Andrea De Censi • 29 May 2026
ASCO 2026
Breast Cancer Tamoxifen

Andrea De Censi, MD, Champalimaud Centre, Lisbon, Portugal, discusses low-dose tamoxifen in premenopausal women with breast cancer. Low-dose tamoxifen was well tolerated but is not recommended in premenopausal women due to poor control of residual disease. A beneficial effect was found on control of contralateral disease which could recommend low-dose tamoxifen for breast cancer prevention in at-risk young premenopausal women. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Andrea De Censi

Recommendations for low-dose tamoxifen in pre- and postmenopausal women with breast cancer
0:55
Recommendations for low-dose tamoxifen in pre- and postmenopausal women with breast cancer
Andrea De Censi • 29 May 2026
Low-dose tamoxifen for early breast cancer by menopausal status
1:57
Low-dose tamoxifen for early breast cancer by menopausal status
Andrea De Censi • 29 May 2026
Low-dose tamoxifen for the treatment of high-risk breast cancer
0:59
Low-dose tamoxifen for the treatment of high-risk breast cancer
Andrea De Censi • 6 Dec 2022
10-year results of a Phase III trial of low-dose tamoxifen in non-invasive breast cancer
1:32
10-year results of a Phase III trial of low-dose tamoxifen in non-invasive breast cancer
Andrea De Censi • 6 Dec 2022

Related Videos

Recommendations for low-dose tamoxifen in pre- and postmenopausal women with breast cancer
0:55
Recommendations for low-dose tamoxifen in pre- and postmenopausal women with breast cancer
Andrea De Censi • 29 May 2026
Pre-pectoral IBBR and oncologic safety following mastectomy
1:20
Pre-pectoral IBBR and oncologic safety following mastectomy
Walter Weber • 30 May 2026
Results from the PREPEC trial support pre-pectoral positioning for IBBR following mastectomy
0:48
Results from the PREPEC trial support pre-pectoral positioning for IBBR following mastectomy
Walter Weber • 30 May 2026
Creating a digital support group for patients with breast cancer in Saudi Arabia
2:11
Creating a digital support group for patients with breast cancer in Saudi Arabia
Atlal Abusanad • 31 May 2026
The content of VJOncology is intended for healthcare professionals